Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
Companies
» Company Monitoring Page for OncoGenex
Company Monitoring Page for OncoGenex
latest headlines for company on cafepharma
OncoGenex scrambles after trial fail
BioPharma Dive
Tue, 08/16/16 - 11:24 am
Tags:
OncoGenex
,
clinical trials
,
prostate cancer
,
custirsen
6 Biotechs Seriously on the Move
24/7 Wall St
Fri, 06/3/16 - 10:47 am
Tags:
biotech
,
Eleven Biotherapeutics
,
Achaogen
,
Repros Therapeutics
,
OncoGenex
,
Cellectar
,
Keryx
OncoGenex slashes 27% of its payroll as its pipeline promise fades
Fierce Biotech
Fri, 02/5/16 - 12:51 pm
Tags:
OncoGenex
,
layoffs
,
custirsen
OncoGenex shares fall after release of prostate cancer study data
Marketwatch
Wed, 12/2/15 - 09:25 am
Tags:
OncoGenex
,
prostate cancer
,
custirsen
OncoGenex's drug misses the mark in pancreatic cancer
Fierce Biotech
Wed, 09/23/15 - 09:58 am
Tags:
OncoGenex
,
pancreatic cancer
,
apatorsen
,
Celgene
,
Abraxane
With Teva out, OncoGenex shrinks its PhIII lung cancer study
Fierce Biotech
Thu, 04/30/15 - 10:45 am
Tags:
Teva Pharmaceutical
,
OncoGenex
,
non-small cell lung cancer
,
custirsen
OncoGenex Regains Rights to Custirsen from Teva
Yahoo
Mon, 04/27/15 - 09:43 am
Tags:
OncoGenex
,
custirsen
,
Teva Pharmaceutical
,
lung cancer
,
prostate cancer
OncoGenex to Regain Rights to Custirsen from Teva
Yahoo
Tue, 12/30/14 - 10:27 am
Tags:
OncoGenex
,
Teva Pharmaceutical
,
custirsen
,
lung cancer
,
prostate cancer
OncoGenex's Phase III Prostate Cancer Study Fully Enrolled
Yahoo/Zacks.com
Fri, 09/19/14 - 08:51 am
Tags:
OncoGenex
,
prostate cancer
,
Jevtana
OncoGenex Says Lung Cancer Drug Trial Will Continue
Drug Discovery and Development
Fri, 08/22/14 - 11:36 am
Tags:
OncoGenex
,
clinical trials
,
custirsen
,
non-small cell lung cancer
The Biggest Biotech Catastrophes of the Week
Motley Fool
Wed, 05/7/14 - 03:36 pm
Tags:
biotech
,
vintafolide
,
Endocyte
,
OncoGenex
,
custirsen
,
Athersys
,
MultiStem
OncoGenex, Teva say prostate cancer drug fails trial
Yahoo/Reuters
Mon, 04/28/14 - 10:16 am
Tags:
Teva Pharmaceuticals
,
OncoGenex
,
prostate cancer
,
custirsen
OncoGenex Has A Potential Blockbuster Drug, But The Markets Are Pricing It Like An Orphan
Seeking Alpha
Tue, 01/28/14 - 10:55 am
Tags:
OncoGenex
,
Isis Pharmaceuticals
,
Teva Pharmaceuticals
,
chemotherapy
,
OGX-011
Can OncoGenex Pharma (OGXI) Continue to Rise?
Yahoo/Zacks.com
Thu, 01/16/14 - 06:53 am
Tags:
OncoGenex
OncoGenex's Apatorsen in Phase II Study
Yahoo/Zacks
Thu, 08/29/13 - 09:40 am
Tags:
OncoGenex
,
apatorsen
,
metastatic pancreatic cancer
,
Gemzar
,
Celgene
,
Abraxane
,
OGX-427
Lower-than-Expected Loss at OncoGenex
Yahoo/Zacks
Tue, 08/13/13 - 10:49 am
Tags:
earnings
,
OncoGenex
Teva rises on cancer updates
Globes, Israel
Sun, 08/11/13 - 11:17 am
Tags:
Teva
,
Lonquex
,
OncoGenex
,
Custiren
,
prostate cancer
,
metastatic castration-resistant prostate cancer
,
chemotheraphy-induced neutropenia
,
neutropenia
OncoGenex to Webcast Discussion of Clinical Development Program and Second Quarter 2013 Financial Results on August 8, 2013
MarketWatch
Wed, 07/31/13 - 10:08 am
Tags:
OncoGenex
,
earnings
OncoGenex initiates clincal trial of OGX-427
The Fly on the Wall
Tue, 04/30/13 - 08:58 am
Tags:
OGX-427
,
OncoGenex
,
bladder cancer
OncoGenex Loss Lower than Expected
Yahoo/Zacks
Tue, 03/12/13 - 11:37 am
Tags:
OncoGenex
,
earnings
Pages
1
2
3
next ›
last »
last 30 twitter posts
current feelings about your job
job rating
*
1 - I hate my job
2
3
4
5
6
7 - I love my job
Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
please tell us why
*
your industry
*
your job title (optional)
your company
*
published
N/A
published
not published
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
cafepharma is a: rock, tree, site
*
Fill in the blank.